Consultation Opened on Amendments to
Pharmaceutical Pricing

Switzerland is moving ahead with the implementation of the Cost Containment Package 2: On 18 February 2026, the Federal Council opened the consultation on a third set of significant revisions to the Health Insurance Ordinance ("HIO") and the Ordinance on the Benefits under the Mandatory Health Insurance ("OBHI"). The new provisions implement notable changes in pharmaceutical pricing. They include turnover-based refund models, confidential pricing models, reimbursement as of the marketing authorisation date, and a differentiated assessment of effectiveness, appropriateness and economic efficiency ("WZW"). The consultation is open until 26 May 2026.